Radiation-induced small extracellular vesicles as "carriages" promote tumor antigen release and trigger antitumor immunity

• Published in: Theranostics 2020-01, Vol.10 (11), p.4871-4884
• Main Authors: Lin, Wanzun, Xu, Yanyan, Chen, Xiaochuan, Liu, Jun, Weng, Youliang, Zhuang, Qingyang, Lin, Feifei, Huang, Zongwei, Wu, Shihong, Ding, Jianming, Chen, Long, Qiu, Xianxin, Zhang, Lurong, Wu, Junxin, Lin, Duo, Qiu, Sufang
• Format: Article
• Language: English
• Subjects: Animals; Antigens; Antigens, Neoplasm - immunology; Antigens, Neoplasm - metabolism; Breast cancer; Breast Neoplasms - immunology; Breast Neoplasms - metabolism; Breast Neoplasms - pathology; Breast Neoplasms - radiotherapy; Cancer therapies; Cancer Vaccines - immunology; Cell Adhesion Molecules - immunology; Cell Line, Tumor; Cytotoxicity; Disease Models, Animal; Extracellular vesicles; Extracellular Vesicles - immunology; Extracellular Vesicles - metabolism; Extracellular Vesicles - radiation effects; Female; Flow cytometry; Immunity, Cellular; Liver Neoplasms - immunology; Liver Neoplasms - metabolism; Liver Neoplasms - radiotherapy; Liver Neoplasms - secondary; Lymphocytes; Metastasis; Mice; Mice, Inbred BALB C; Nanoparticles; Peptides - immunology; Proteins; Radiation therapy; Radiotherapy - methods; Research Paper; T-Lymphocytes - immunology; T-Lymphocytes - metabolism; T-Lymphocytes - radiation effects; Transmission electron microscopy; Tumors
• ISSN: 1838-7640; 1838-7640
• DOI: 10.7150/thno.43539

: Accumulating evidence supports the importance of radiation therapy in the induction of antitumor immunity. Small extracellular vesicles (sEVs) play essential roles in tumor antigen loading and delivery. However, the role of sEVs in radiation-induced antitumor immunity remains unclear. It is therefore important to determine the role and regulatory mechanisms of sEVs in radiation-induced immunity. : Tumor cells were irradiated (8 Gy), and sEVs were purified via ultracentrifugation. Primary tumor and experimental lung metastasis models were established in mice to evaluate antitumor immunity triggered by immunization with sEVs. Proteomic and bioinformatic analyses were performed to identify altered cargos in sEVs induced by radiation. Peptides derived from up-regulated proteins in sEVs were designed and synthesized as vaccines according to major histocompatibility complex (MHC) I binding and immunogenicity. : Here, we demonstrated that sEVs derived from irradiated tumor cells could trigger antitumor immunity against primary tumor and experimental lung metastasis by enhancing CD8 and CD4 T cell infiltration. Radiation may also enrich sEVs with tumor antigens and heat-shock proteins. Furthermore, CUB domain-containing protein 1 (CDCP1) derived from radiation-induced sEVs was identified as a novel tumor-associated antigen and developed as a peptide vaccine that may generate antitumor immune responses. : Our results demonstrate that the use of sEVs secreted by irradiated tumor cells constitutes an efficient approach for tumor antigen delivery and presentation and highlight the role of sEVs in radiation-triggered antitumor immunity.